Therefore, the lower expression of EAT PGC1α and UCP1 from CAD patients found in our study suggests a loss of EAT brown-like features in DM2, which may act detrimentally on metabolism [18, 19] and promote the progression and severity of CAD [9]. Here, PPARGC1A is linked to coronary artery disorder.